Hennion & Walsh Asset Management, Inc. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
Hennion & Walsh Asset Management, Inc. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$8,301,184
+85276.8%
523,074
+1.5%
0.53%
-8.3%
Q2 2023$9,723
+426.7%
515,279
+7.2%
0.58%
+410.6%
Q1 2023$1,846
-20.7%
480,737
+2.4%
0.11%
-21.5%
Q4 2022$2,329
-99.9%
469,637
+41.1%
0.14%
+37.1%
Q3 2022$1,591,000
+14.3%
332,874
+7.6%
0.10%
+22.1%
Q2 2022$1,392,000
+49.0%
309,334
+57.7%
0.09%
+72.0%
Q1 2022$934,000
+6.0%
196,146
+65.2%
0.05%
+16.3%
Q4 2021$881,000118,7190.04%
Other shareholders
IMMUNOGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 10,906,962$69,914,0003.04%
Fernwood Investment Management, LLC 224,500$1,439,0000.77%
Telemetry Investments, L.L.C. 272,000$1,744,0000.66%
Schonfeld Strategic Advisors LLC 865,356$5,547,0000.45%
Virtus ETF Advisers LLC 53,977$346,0000.43%
Endurant Capital Management LP 210,800$1,351,0000.41%
SPHERA FUNDS MANAGEMENT LTD. 500,000$3,205,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$726,0000.37%
Orbimed Advisors 2,834,126$18,167,0000.23%
PINNACLE ASSOCIATES LTD 1,322,231$8,476,0000.16%
View complete list of IMMUNOGEN INC shareholders